Deerfield Management Company, L.P. (Series C) Immunocore Holdings PLC Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$27.98 - $40.0 $10.1 Million - $14.4 Million	-360,966 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.22 - $41.5 $6.09 Million - $7.85 Million	189,058 Added 109.98%	360,966 $14.1 Million
Q1 2021 May 17, 2021	BUY	$36.3 - $56.34 $6.24 Million - $9.69 Million	171,908 New	171,908 $7.32 Million

Others Institutions Holding IMCR

# of Institutions

141

Shares Held

41.4M

Call Options Held

197K

Put Options Held

451K

Wellington Management Group LLP Boston, MA

7.05M
Shares

$217 Million
0.04% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

6.5M
Shares

$200 Million
0.12% of portfolio
Rtw Investments, LP New York, NY

4.87M
Shares

$150 Million
2.42% of portfolio
Primecap Management CO Pasadena, CA

2.47M
Shares

$76.1 Million
0.06% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.16M
Shares

$66.4 Million
0.01% of portfolio

View Full List

About Immunocore Holdings plc

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.35B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

More about IMCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account